Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0515 Transporter Info
Gene Name	ATP10A
Transporter Name	Probable phospholipid-transporting ATPase VA
Gene ID	57194
UniProt ID	O60312

Post-Translational Modification of This DT
Overview of ATP10A Modification Sites with Functional and Structural Information
Sequence	M E R E P A G T E E P G P P G R R R R R E G R T R T V R S N L L P P P G A E D P A A G A A K G E R R R R R G C A Q H L A D N R L K T T K Y T L L S F L P K N L F E Q F H R P A N V Y F V F I A L L N F V P A V N A F Q P G L A L A P V L F I L A I T A F R D L W E D Y S R H R S D H K I N H L G C L V F S R E E K K Y V N R F W K E I H V G D F V R L R C N E I F P A D I L L L S S S D P D G L C H I E T A N L D G E T N L K R R Q V V R G F S E L V S E F N P L T F T S V I E C E K P N N D L S R F R G C I I H D N G K K A G L Y K E N L L L R G C T L R N T D A V V G I V I Y A G H E T K A L L N N S G P R Y K R S K L E R Q M N C D V L W C V L L L V C M S L F S A V G H G L W I W R Y Q E K K S L F Y V P K S D G S S L S P V T A A V Y S F L T M I I V L Q V L I P I S L Y V S I E I V K A C Q V Y F I N Q D M Q L Y D E E T D S Q L Q C R A L N I T E D L G Q I Q Y I F S D K T G T L T E N K M V F R R C T V S G V E Y S H D A N A Q R L A R Y Q E A D S E E E E V V P R G G S V S Q R G S I G S H Q S V R V V H R T Q S T K S H R R T G S R A E A K R A S M L S K H T A F S S P M E K D I T P D P K L L E K V S E C D K S L A V A R H Q E H L L A H L S P E L S D V F D F F I A L T I C N T V V V T S P D Q P R T K V R V R F E L K S P V K T I E D F L R R F T P S C L T S G C S S I G S L A A N K S S H K L G S S F P S T P S S D G M L L R L E E R L G Q P T S A I A S N G Y S S Q A D N W A S E L A Q E Q E S E R E L R Y E A E S P D E A A L V Y A A R A Y N C V L V E R L H D Q V S V E L P H L G R L T F E L L H T L G F D S V R K R M S V V I R H P L T D E I N V Y T K G A D S V V M D L L Q P C S S V D A R G R H Q K K I R S K T Q N Y L N V Y A A E G L R T L C I A K R V L S K E E Y A C W L Q S H L E A E S S L E N S E E L L F Q S A I R L E T N L H L L G A T G I E D R L Q D G V P E T I S K L R Q A G L Q I W V L T G D K Q E T A V N I A Y A C K L L D H D E E V I T L N A T S Q E A C A A L L D Q C L C Y V Q S R G L Q R A P E K T K G K V S M R F S S L C P P S T S T A S G R R P S L V I D G R S L A Y A L E K N L E D K F L F L A K Q C R S V L C C R S T P L Q K S M V V K L V R S K L K A M T L A I G D G A N D V S M I Q V A D V G V G I S G Q E G M Q A V M A S D F A V P K F R Y L E R L L I L H G H W C Y S R L A N M V L Y F F Y K N T M F V G L L F W F Q F F C G F S A S T M I D Q W Y L I F F N L L F S S L P P L V T G V L D R D V P A N V L L T N P Q L Y K S G Q N M E E Y R P R T F W F N M A D A A F Q S L V C F S I P Y L A Y Y D S N V D L F T W G T P I V T I A L L T F L L H L G I E T K T W T W L N W I T C G F S V L L F F T V A L I Y N A S C A T C Y P P S N P Y W T M Q A L L G D P V F Y L T C L M T P V A A L L P R L F F R S L Q G R V F P T Q L Q L A R Q L T R K S P R R C S A P K E T F A Q G R L P K D S G T E H S S G R T V K T S V P L S Q P S W H T Q Q P V C S L E A S G E P S T V D M S M P V R E H T L L E G L S A P A P M S S A P G E A V L R S P G G C P E E S K V R A A S T G R V T P L S S L F S L P T F S L L N W I S S W S L V S R L G S V L Q F S R T E Q L A D G Q A G R G L P V Q P H S G R S G L Q G P D H R L L I G A S S R R S Q
PTM type	X-Acetylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	985
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP10A Lysine 985 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP10A			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	990
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ATP10A Lysine 990 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	544
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ATP10A Cystine 544 has the potential to affect its expression or activity.
Phosphorylation
Serine	12 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 426 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP10A			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	466
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 466 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP10A			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	483
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 483 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP10A			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	501
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 501 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP10A			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 515 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP10A			[9] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	518
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 518 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP10A			[12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	524
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 524 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP10A			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	780
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 780 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP10A			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	781
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 781 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ATP10A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1037
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 1037 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ATP10A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1049
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 1049 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ATP10A			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	1060
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Serine 1060 has the potential to affect its expression or activity.
Threonine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	8
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 8 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP10A			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	286
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 286 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 415 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	429
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 429 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	431
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 431 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	433
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 433 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ATP10A			[8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	505
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 505 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ATP10A			[9] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	521
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 521 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ATP10A			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	962
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 962 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ATP10A			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	964
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 964 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ATP10A			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	1026
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Threonine 1026 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Tyrosine 258 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ATP10A			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Tyrosine 281 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ATP10A			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	423
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Tyrosine 423 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ATP10A			[5] , [17]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	461
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ATP10A Tyrosine 461 has the potential to affect its expression or activity.
Ubiquitination
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[15]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP10A Alanine 123 has the potential to affect its expression or activity.
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	428
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP10A Lysine 428 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ATP10A			[15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ATP10A Tyrosine 281 has the potential to affect its expression or activity.

References
1	AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment. Cardiovasc Drugs Ther. 2014 Apr;28(2):183-9.
2	Residents' experiences with legal issues in psychiatry. Acad Psychiatry. 1989 Jun;13(2):103-5.
3	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
4	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
5	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
6	Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Mol Syst Biol. 2018 Mar 5;14(3):e7858.
7	Phosphoproteome dynamics in onset and maintenance of oncogene-induced senescence. Mol Cell Proteomics. 2014 Aug;13(8):2089-100.
8	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
9	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
10	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
11	Comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane between normal and preeclampsia pregnancies with high-resolution mass spectrometry. PLoS One. 2013 Nov 15;8(11):e80480.
12	Insights into chemoselectivity principles in metal oxide affinity chromatography using tailored nanocast metal oxide microspheres and mass spectrometry-based phosphoproteomics. Analyst. 2017 May 30;142(11):1993-2003.
13	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
14	Integrated analysis of global proteome, phosphoproteome, and glycoproteome enables complementary interpretation of disease-related protein networks. Sci Rep. 2015 Dec 11;5:18189.
15	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
16	Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
17	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence